Affymax, Inc.
Affymax, Inc., a prominent biotechnology company headquartered in the United States, has been at the forefront of innovative therapies since its founding in 1997. Specialising in the development of novel treatments for patients with chronic kidney disease, Affymax has made significant strides in the biopharmaceutical industry, particularly with its flagship product, Omontys (peginesatide), which offers a unique approach to anaemia management. With a focus on enhancing patient outcomes, Affymax has established a strong market position through its commitment to research and development. The company’s dedication to advancing healthcare solutions has garnered recognition within the industry, marking it as a key player in the biotechnology sector. As it continues to evolve, Affymax remains dedicated to delivering transformative therapies that address unmet medical needs.
DitchCarbon Score
How does Affymax, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Household Employment industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Affymax, Inc.'s score of 23 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Affymax, Inc.'s reported carbon emissions
Affymax, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Affymax may not have established formal commitments to address carbon emissions or climate change initiatives at this time. As such, the company does not appear to be actively participating in industry-standard climate frameworks or initiatives like the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP).
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Affymax, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
